Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 161-180 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 161 | Antaris Inc. lowweak | Opp 2 Risk 2 | Thesis: Antaris may have strategic opportunity based on the membership rationale referencing private space software work, LEO ISR/optical communications architecture, a JANUS-2 mission, and self-healing satellite capability for the U.S. Space Force, but the reviewed sources includes no retained recent evidence window-window evidence to support scoring that thesis now. Why now: There is no retained 90-day evidence in these reviewed sources despite references to evidence in earlier processing. Recency-sensitive conclusions therefore cannot be made from the local reviewed sources. Caveats: Membership rationale references older evidence but no article IDs are provided with accessible summaries in these reviewed sources body. No representative articles or retained evidence are included. Low score reflects evidence absence, not a negative business judgment. |
| 162 | Antaris Inc. lowweak | Opp 2 Risk 1 | Thesis: There is a faint opportunity signal because the phase2 rationale states Antaris appeared as part of an investment issuer's portfolio after a $28 million Series A, which suggests access to capital, but the reviewed sources does not provide the underlying citable event text in the scoring evidence fields. Why now: Why now is weak: the only reviewed sources signal is the phase2 rationale mentioning a post-Series A portfolio reference tied to article, but no representative article summary or direct evidence row is included here to establish timing or business impact. Caveats: The cited Series A context appears only in phase2 rationale rather than in stronger scoring evidence fields. No product, customer, or execution evidence is provided. |
| 163 | Applied Atomics lowweak | Opp 2 Risk 3 | Thesis: Applied Atomics may have long-horizon optionality as a startup developing in-space mobility/orbital logistics concepts, but the reviewed sources provide no available article or evidence inside the recent evidence window to support a stronger opportunity score. Why now: There is no available dated evidence in the reviewed sources after recent evidence filtering, so recency-based ranking support is weak. Caveats: No representative articles or evidence are available after recent evidence filtering for ranking support. The phase2 membership rationale mentions a $4M pre-seed and Star Reacher Network, but the cited supporting articles are not provided with usable article summaries or evidence in these reviewed sources. |
| 164 | Astranis Space Technologies lowweak | Opp 2 Risk 2 | Thesis: Phase-2 rationale states Astranis was selected by the U.S. Space Force for the Andromeda contract for next-generation space domain awareness/surveillance satellites, which would be positive if current and retained, but the present reviewed sources contain no in-window evidence to substantiate it. Why now: The current batch retains no representative articles or evidence within the 90-day recent evidence window for Astranis, so the reviewed sources does not provide a current dated catalyst despite the phase-2 rationale. Caveats: No retained evidence after recent evidence window. Phase-2 rationale mentions duplicate article versions; duplicates would not be independent confirmation anyway. |
| 165 | Astrobotic Technology lowweak | Opp 2 Risk 2 | Thesis: The membership rationale says Astrobotic operates the Griffin lunar lander and is a CLPS contractor, which is strategically relevant for a 1 year+ horizon, but the reviewed sources supplies no available within the recent evidence window direct positive evidence or dated article summaries for scoring. Why now: The rationale references articles, and: but no corresponding available evidence remains available for direct scoring after recent evidence filtering. Caveats: Lunar lander category fit does not equal thesis attractiveness. Coverage debug shows zero available evidence after recent evidence window. Without direct execution, funding, contract-conversion, or mission-status evidence, scores should remain conservative. |
| 166 | Astrolight lowweak | Opp 2 Risk 1 | Thesis: Membership rationale indicates Astrolight is a private space/defense startup developing laser communication terminals for space, with ESA contracts and deployed terminals, which could support a 1 year+ growth thesis in optical communications if verified by direct evidence. Why now: Why now is weak because the reviewed sources cites support article: in membership rationale, but no, article summary, or retained evidence are provided after the 90-day filter. Caveats: Potentially strong fundamentals are only referenced in membership rationale without citable article details. Coverage data shows zero articles after recent evidence window and zero evidence after recent evidence window. Private-company status also limits external validation in these reviewed sources. |
| 167 | Astrolight UAB lowweak | Opp 2 Risk 2 | Thesis: Astrolight UAB may have a long-horizon opportunity if it is providing optical hardware into a Kepler Communications ESA HydRON optical communications network effort, but the reviewed sources lack available direct evidence to confirm Astrolight's own contract position, scope, or recency. Why now: There is no usable 'why now' beyond possible strategic relevance to optical communications. The reviewed sources provide no after-recent evidence window evidence to confirm current status. Caveats: Phase-2 rationale references, but the reviewed sources does not include its or article summary. Relations marked context-only cannot be used as counterparty propagation evidence. Coverage debug shows zero evidence after recent evidence window. |
| 168 | Astrome lowweak | Opp 2 Risk 1 | Thesis: Reviewed evidence rationale says Astrome was among spacetech startups receiving India's RDI fund support, which is directionally positive as non-dilutive or supportive capital context, but no underlying article or dated event evidence is present in the available recent evidence window dataset. Why now: Why now is weak because the support exists only in the phase-2 rationale; coverage data shows zero evidence after recent evidence window, so timing and durability of the funding support cannot be verified from local evidence. Caveats: No direct article or event evidence is available after recent evidence window. Government-support statement is not accompanied by a dated in-window source in the reviewed sources. Low confidence due to sparse evidence. |
| 169 | Atomos Space lowweak | Opp 2 Risk 1 | Thesis: A very modest opportunity case exists only because retained undated supporting context lists Atomos Space as an operating in-orbit servicing company, which at least suggests ongoing activity in a strategically relevant segment, but this is supporting article context rather than direct company event evidence. Why now: Why now is limited and recency is uncertain: the only retained evidence is undated supporting context, so it cannot establish a fresh catalyst, only background relevance, article date_basis: undated). Evidence
Caveats: The evidence is undated, and the reviewed sources explicitly says to treat undated external evidence as relevance context rather than recency proof. The retained rows are weak context and neutral polarity, not positive evidence. Same article repeated rows are not independent confirmation. |
| 170 | Azista Space lowweak | Opp 2 Risk 2 | Thesis: Reviewed evidence membership rationale says Azista Space built the satellite bus/payload for GalaxEye's Drishti Earth Observation Satellite, which implies real manufacturing participation and possible long-horizon opportunity, but no direct evidence or article are available in the served reviewed sources. Why now: Why now is weak because there is no surviving 90-day evidence row in the reviewed sources to establish recency or momentum. Caveats: Only membership rationale is available; no citeable direct evidence with are provided. Single-article universe increases fragility of inference. |
| 171 | Blackstar Orbital lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources rationale suggests Blackstar Orbital is described as a hypersonic/reusable spacecraft testing partner with mention of a reusable hypersonic satellite concept, which could imply technology optionality if substantiated and, no provided in reviewed sources). However, the evidence retained here is not direct and no positive events are available after recent evidence window. Why now: No near-term or durable catalyst can be established from retained evidence because coverage debug shows zero article IDs and zero evidence after recent evidence window. Caveats: No are provided for the cited support articles in the reviewed sources. The reviewed sources explicitly characterizes the evidence as mostly partnership context rather than direct operating detail. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. |
| 172 | Brightside Group S.A. lowweak | Opp 2 Risk 2 | Thesis: Membership rationale indicates Brightside is advancing a €415M sovereign satellite program and provides a sovereign satellite platform via partnership with SES, which could be meaningful if current, but the reviewed sources exposes no direct within the recent evidence window evidence or article summaries to substantiate a current opportunity thesis. Why now: Why now is weak because no representative article or direct evidence survives in the ranking fields after recent evidence window; only membership rationale references without surfaced article content. Caveats: No direct within the recent evidence window evidence is available in ranking fields. Membership rationale alone is weaker than surfaced company-specific event evidence. No negative thesis is supportable from the reviewed sources. |
| 173 | BULL Co., Ltd. lowweak | Opp 2 Risk 1 | Thesis: The membership rationale says BULL signed an agreement with Fujitsu to develop a high-precision space situational awareness service for Japan, which is directionally positive, but there is no retained within the recent evidence window article evidence or in the reviewed sources to support a stronger opportunity thesis. Why now: No within the recent evidence window evidence were retained, so there is no strong timing signal for a 1 year+ ranking beyond weak membership context. Caveats: Membership rationale references articles and, but the reviewed sources does not provide or retained evidence. Potential commercial significance cannot be sized from the reviewed sources. |
| 174 | Calian Group Ltd. lowweak | Opp 2 Risk 1 | Thesis: There is some older membership support that the Canadian Space Agency awarded Calian funds for RADARSAT+ ground-segment concept studies via article: which could indicate space-contract relevance, but no retained in-window evidence with supports a stronger current opportunity thesis. Why now: Why now is weak because the reviewed sources retained no evidence after recent evidence window for Calian, so no current catalyst is evidenced. Caveats: Reviewed evidence mentions: but provides no, preventing direct citation as scored evidence. No retained 90-day evidence. Opportunity case depends on uncited older context rather than current business-state confirmation. |
| 175 | CAS Space lowweak | Opp 2 Risk 3 | Thesis: CAS Space may have long-horizon opportunity as a reusable rocket developer and launch provider, but the ranking reviewed sources provide no available supporting evidence within the recent evidence window. Why now: There is no usable dated evidence available after recent evidence filtering, so the reviewed sources does not provide a clear timing catalyst. Caveats: The membership rationale references an IPO and Lijian-1 launch activity, but those source articles are not included with ranking-usable details in these reviewed sources. |
| 176 | CAS Space lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources rationale says CAS Space is among Chinese rocket/satellite companies advancing IPO or pre-IPO plans, which could be a strategic opportunity signal if supported by company-specific evidence (: and: no provided in reviewed sources). Why now: There is no verified current catalyst in retained evidence. IPO/pre-IPO framing could matter on a 1 year+ horizon, but recency and milestone state cannot be confirmed here because no dated evidence are available after recent evidence window. Caveats: No are provided for the cited support articles in the reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. IPO/pre-IPO mention is only in reviewed sources rationale, not in retained direct evidence. |
| 177 | Citra Space Corp lowweak | Opp 2 Risk 1 | Thesis: The membership rationale says Citra Space raised a $15M Series A to advance space object identification technology, which would ordinarily be positive, but the reviewed sources provide no retained within the recent evidence window article evidence or to ground a stronger opportunity call. Why now: There is no usable within the recent evidence window article evidence available for ranking; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so any current catalyst judgment would be speculative. Caveats: Membership rationale references article, but the reviewed sources does not provide the article or retained ranking evidence inside the recent evidence window. Because direct evidence arrays are empty, the small positive score reflects only weak contextual possibility, not high-confidence attractiveness. |
| 178 | Cosmoserve Space lowweak | Opp 2 Risk 2 | Thesis: Reviewed evidence membership rationale says Cosmoserve Space is a private space sustainability company working on debris removal, with Pixxel providing a satellite bus for its demo mission. That suggests a real mission path, but there are no citeable direct evidence or in the served reviewed sources. Why now: Why now is weak because the reviewed sources does not establish current demo timing or funding status with direct evidence after recent evidence window. Caveats: Private company with thin visible evidence in these reviewed sources. Mission/demo status cannot be validated from available evidence. |
| 179 | Curtiss-Wright Corporation lowweak | Opp 2 Risk 1 | Thesis: Curtiss-Wright has modest contextual opportunity because the membership rationale describes it as a ruggedized electronics supplier benefiting from broader space spending, which could align with a durable 1 year+ strategic cycle if backed by company-specific orders or segment growth evidence (: unavailable in reviewed sources). But the reviewed sources contain no direct positive evidence within the recent evidence window. Why now: Potentially relevant if broader space spending is increasing, but the reviewed sources provide no retained dated evidence, no current data, so timing and magnitude cannot be validated. Caveats: No current evidence is provided for Relation/context evidence must not be used as counterparty propagation; reviewed sources notes context only. No available direct evidence after recent evidence window despite high article count considered. |
| 180 | Deloitte lowweak | Opp 2 Risk 1 | Thesis: There is some indication of meaningful space activity, but not enough retained direct evidence to make a strong 1 year+ opportunity call. Why now: The reviewed sources rationale says Deloitte launched satellites for Project Constellation to test on-orbit cyber protections and contracted Spire to design, build, and operate satellites, citing article, but no or retained evidence row is available after recent evidence window, limiting confidence. Caveats: The described activity comes only from membership rationale rather than retained evidence. Without retained dated evidence or, chronology and durability cannot be tested. |
Risk view
Showing rows 21-40 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 21 | Capella Space highstrong | Opp 8 Risk 4 | Thesis: Risk is present but not thesis-dominant: Capella is undertaking defense-oriented prototype work and broader strategic expansion beyond commercial SAR, which can carry execution complexity, but the reviewed sources contain no direct adverse evidence within the recent evidence window. Why now: The April 8, 2026 SDA award is recent within the recent evidence window and is directly relevant to a 1 year+ horizon because it funds spacecraft design and development for a government demonstration program. Later context articles in April-June 2026 continue to depict Capella as an operating SAR platform with defense exposure. Evidence
Caveats: The positive contract evidence is classified as a neutral supporting fact in the reviewed sources, so direction is inferred from the business substance rather than explicit positive polarity labeling. Several contextual articles mention a planned acquisition or subsidiary status, but time-sensitive ownership/public-status interpretations should be treated cautiously because not all such references are direct, dated transaction-closing evidence. For example, and |
| 22 | Cowboy Space mediummedium | Opp 7 Risk 4 | Thesis: Execution risk is meaningful because the business combines new rocket development with orbital data-center infrastructure, and one cited article says the first launch is expected before the end of 2028, implying a long path from capital raise to operational proof. Why now: Multiple dated articles on May 11, 2026 report Cowboy Space raised $275 million in Series B financing at a $2 billion valuation to build rockets with orbital data-center upper stages, and a TechCrunch article says the company is standing up its own rocket program with a first launch expected before end-2028 Evidence
Caveats: The reviewed sources contain no explicit negative event evidence; risk is inferred from execution complexity and long timeline, not from adverse events. Several supporting rows repeat the same May 11, 2026 financing story and are not independent confirmation. Some supporting article context is undated and should be treated cautiously for recency. |
| 23 | Eutelsat Communications SA mediummedium | Opp 7 Risk 4 | Thesis: Risk remains meaningful because the ranking payload contains no kept direct evidence or representative articles for those claims, so the thesis depends on membership-support statements without available article detail, economics, or recency granularity beyond inclusion in the recent evidence windowed reviewed sources. Why now: The reviewed sources' membership rationale cites current program/contract relevance through support articles 2026-04, and: but were not provided in the payload, limiting precise timing narration. Evidence
Caveats: The reviewed sources does not provide for the membership-support article IDs. Opportunity score is tempered by the absence of kept direct evidence in the ranking payload. |
| 24 | GalaxEye mediummedium | Opp 7 Risk 4 | Thesis: Risk remains meaningful because the reviewed sources does not provide direct evidence of post-launch operational performance, customer revenue conversion, or successful scaling beyond the first satellite. Funding references are inconsistent across articles, and planned next-round financing after commissioning indicates continued capital dependence. Why now: The key timing change is that earlier pre-launch coverage from April 23, 2026 was followed by launch coverage on May 3, 2026/May 4, 2026, and later June 16, 2026 context states the first satellite was launched in May 2026, confirming a business-state transition from concept/pre-launch to deployed asset status. The NSIL resale agreement was reported earlier on February 13, 2026, giving a potential go-to-market bridge once satellite data is available. Evidence
Caveats: Most reviewed sources rows are neutral facts or supporting article context rather than explicit positive evidence. Funding totals vary across articles (~$14.5M, $18.3M, ~$20M), so exact capitalization is uncertain |
| 25 | Globalstar lowweak | Opp 3 Risk 4 | Thesis: Risk is moderate because evidence coverage is absent inside the 90-day recent evidence window, making business-state, ownership, and catalyst timing uncertain for a 1 year+ ranking. Why now: There is effectively no why-now evidence in this row: the recent evidence review shows zero kept rows after the March 29, 2026 cutoff and no representative articles are provided. Caveats: The phase-2 rationale mentions Amazon acquisition-related articles, but those supporting articles are not included in the available evidence for this row. Scores remain low because absence of evidence is not positive evidence. |
| 26 | HyPrSpace lowweak | Opp 3 Risk 4 | Thesis: Risk is somewhat higher than opportunity because launch development is technically demanding and capital intensive, and the reviewed sources provide no available direct event evidence beyond the membership rationale to confirm de-risking milestones within the recent evidence window. Why now: The reviewed sources does not provide recent evidence window-supported article details for the cited raise and development milestones, so the timing case is under-evidenced. Caveats: No representative articles or direct evidence are available after recent evidence filtering. The opportunity view rests only on the membership rationale rather than article-level evidence available for citation. |
| 27 | Impulse Space mediummedium | Opp 8 Risk 4 | Thesis: Main risk is execution risk after a very large private financing round: the reviewed sources confirms capital raised, but does not provide within the recent evidence window direct evidence of completed commercial deployments or revenue realization. The article context says valuation was undisclosed, adding some uncertainty around terms and expectations. Why now: The catalyst is recent and dated: on June 2, 2026/June 3, 2026, Impulse Space disclosed a $500 million Series D and total capital raised above $1 billion, which is highly relevant for a 1 year+ scaling thesis. Evidence
Caveats: Some supportive items are supporting article context and should not be treated as independent confirmation if repeating the same financing announcement. Older commercial contract and government contract references in representative articles are outside the 90-day recent evidence window and therefore not primary recency support here. |
| 28 | Impulse Space lowweak | Opp 4 Risk 4 | Thesis: Risk is not based on direct adverse evidence; instead it reflects defense-program execution uncertainty and lack of currently available corroboration for program status, milestones, or revenue conversion, unavailable in reviewed sources). Why now: Why now is only medium because defense-space prototype work can matter over a 1 year+ horizon, but the reviewed sources' available evidence is empty after recent evidence window, preventing higher-conviction ranking. Caveats: No current evidence is provided for. No direct evidence remained after the recent evidence filter. Potential opportunity rests on membership rationale rather than available corroborated evidence. |
| 29 | Isar Aerospace mediummedium | Opp 5 Risk 4 | Thesis: Risk is also elevated because the same recent context ties the thesis to a near-term launch outcome and milestone execution; the opportunity appears highly contingent on launch success, making binary execution risk material over a 1 year+ horizon. Why now: Recent supporting article context within the recent evidence window supports timing: is dated June 9, 2026 and states Isar raised €270 million and had a June 15-21 Spectrum launch window from Andoya. Date basis is source date. Evidence
Caveats: Evidence is supporting article context only and appears under weak context, not direct dated events. Positive and risk interpretations come from the same article and are not independent confirmation. |
| 30 | ispace lowweak | Opp 3 Risk 4 | Thesis: Reviewed evidence rationale explicitly notes this is ispace's 'second attempt after 2023 failure,' which raises meaningful execution risk for a mission-driven thesis. With no direct positive or negative reviewed evidence, the prior failure context remains the clearest directional risk indicator in the reviewed sources. Why now: The membership support cites: and: The reviewed sources' wording around a second attempt makes mission outcome and execution durability relevant over a 1 year+ horizon, but timing confidence is reduced because no evidence survived into the available set. Caveats: Risk thesis is inferred from reviewed sources rationale mentioning a prior failure, not from available direct negative evidence. No direct evidence confirms current mission status, financing, or customer pipeline. Recency and sequencing of mission milestones cannot be validated from the empty evidence table. |
| 31 | Logos Space Services mediummedium | Opp 6 Risk 4 | Thesis: The same evidence implies substantial execution and engineering risk because the planned network is very large and would use higher-frequency K-, Q- and V-band spectrum that can improve capacity but also pose engineering challenges. Why now: A dated article within the 90-day recent evidence window, with based on April 13, 2026, states that Logos Space Services recently secured FCC approval for a constellation of up to 4,178 broadband satellites and described both target customers and technical architecture, making this a timely strategic-development signal for a 1 year+ horizon. Evidence
Caveats: Evidence is supporting article context, not a richer set of direct dated events/facts. Only one article after recent evidence window; same-article repeated rows are not independent confirmation. |
| 32 | Millennium Space Systems mediummedium | Opp 5 Risk 4 | Thesis: Risk remains moderate because the reviewed sources only provides supporting article context, not direct contract economics, scope allocation to Millennium, or follow-on execution milestones. Why now: The relevant evidence is within the recent evidence window: an April 8, 2026 article said the U.S. Space Force awarded 14 companies more than $1.8 billion in Andromeda contracts and included Boeing's Millennium Space Systems, which is potentially durable over a 1 year+ horizon if tasking converts into meaningful work Evidence
Caveats: Evidence is supporting article context, not a company-specific contract award document or structured positive event row. Reviewed evidence does not show Millennium's individual award size or share of the ceiling value. Same article repeated in weak-context rows is not independent confirmation. |
| 33 | NewOrbit Space mediummedium | Opp 4 Risk 4 | Thesis: Risk is also meaningful because the evidence is undated supporting article context, so recency is uncertain; for a business-state claim like financing and current program maturity, lack of date makes it harder to assess whether the capital raise is still a live catalyst or already absorbed. Why now: Why now is weaker than Aavuus because the article has no publication date. The reviewed sources explicitly says no is available and recency-sensitive claims should be treated cautiously., undated Evidence
Caveats: Evidence is supporting article context only, not direct structured positive event evidence. Publication date is unavailable; recency is uncertain. Single-article support only; no independent confirmation. |
| 34 | NordSpace lowweak | Opp 2 Risk 4 | Thesis: Main risk is evidence insufficiency and likely execution uncertainty around an early-stage space venture rather than confirmed adverse developments; the reviewed sources contain no available direct negative evidence within the recent evidence window and no current dated business-state confirmation, unavailable in reviewed sources). Why now: Why now is weak because coverage data shows zero articles after recent evidence window and zero evidence after the 90-day filter, so there is no current catalyst evidence to support a 1 year+ differentiated view from these reviewed sources. Caveats: No article is provided for the membership-support. No direct positive or negative evidence were available after recent evidence window. Private-company status reduces external validation in these reviewed sources. |
| 35 | NorthStar Earth & Space Inc. lowweak | Opp 2 Risk 4 | Thesis: This row carries elevated information risk because the reviewed sources show no recently retained evidence, no representative articles, and no direct positive or negative evidence, while the ticker/public status implications are time-sensitive and unsupported here. Why now: Why-now is weak because the evidence recent evidence review shows zero kept rows after the 90-day cutoff and the row contains no representative articles or direct evidence, so recency and business state are uncertain in these reviewed sources. Caveats: No evidence were available after the recent evidence window for this row. Any statement about public listing, SPAC timing, or operations would be insufficiently grounded from this row alone. Score is driven by evidence absence, not by documented adverse developments. |
| 36 | Northwood Space mediumweak | Opp 6 Risk 4 | Thesis: Risk is still moderate because the visible reviewed sources does not include the underlying article summary or, so the funding signal lacks fuller context such as use of proceeds, valuation, or milestone cadence. Why now: The rationale references article: and states Northwood Space raised $100 million in a notable spacetech funding deal; that size of financing is plausibly durable over a 1 year+ horizon, though recency cannot be fully validated from the absent article body. Caveats: No representative article or provided in the visible evidence body. No direct evidence after recent evidence window are exposed despite the positive rationale. Funding alone does not prove technical or commercial execution. |
| 37 | Obruta Space Solutions lowweak | Opp 4 Risk 4 | Thesis: Current risk is equal to opportunity because the reviewed sources only shows descriptive company-site context and no direct evidence of contracts, funding, launches, or technical milestones. Without validation, the thesis is still conceptual. Why now: The only dated visible evidence is a company-site page with a May 20, 2026 describing the technology and target markets, which is relevant for strategic positioning but not enough to prove commercial inflection within the next year. Evidence
Caveats: Evidence is company-site descriptive context only. No third-party validation, financing, contract, or deployment evidence is shown. |
| 38 | Observable Space lowweak | Opp 4 Risk 4 | Thesis: The reviewed sources provide no direct operating-niche detail, traction, or milestone evidence beyond the funding mention, so execution risk is relatively elevated despite the financing signal. Why now: Why now is the funding mention tied to article ID: but the reviewed sources provide no, operating specifics, or additional corroborating evidence. Caveats: Funding alone is positive evidence but does not prove business quality. Article ID: is referenced without. |
| 39 | Observable Space mediummedium | Opp 8 Risk 4 | Thesis: Risk remains meaningful because most evidence is supporting source context and neutral facts rather than explicit positive events, and the company still appears to be early-stage, contract-execution dependent, and private. Why now: The timing is favorable because on May 28, 2026 the company was reported to have both closed a $90 million Series A and announced a $94 million U.S. Space Force award, with additional follow-on reporting on June 9, 2026 indicating the contract landed just weeks after the raise, suggesting a recent step-change in funding and government traction for a 1 year+ horizon Evidence
Caveats: Positive direction is inferred from neutral facts plus article summaries; the reviewed sources does not provide explicit positive events. Same-article repeated rows are not independent confirmation. Supporting web-search evidence is context and should be treated below directly cited company evidence. |
| 40 | OMSPACE lowweak | Opp 4 Risk 4 | Thesis: Launch development risk is also high because the evidence only shows an early milestone and a future plan for orbital launch capability by 2027. The reviewed sources contain no retained proof of financing, customer backlog, or follow-on technical milestones, so execution risk is substantial. Why now: The reviewed sources' rationale references article: for a successful sounding-rocket launch and a 2027 orbital-launch target, but the underlying article summary/ is not included here, limiting recency and sequence assessment. Caveats: Evidence is limited to a broad membership rationale without article detail. A sounding-rocket success is meaningfully earlier-stage than an orbital launch business. Risk and opportunity are both elevated relative to peers because the technology path is ambitious but still lightly evidenced. |